We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.29B
AUM Growth
-$11.6M
Cap. Flow
-$21.9M
Cap. Flow %
-1.71%
Top 10 Hldgs %
35.16%
Holding
270
New
6
Increased
38
Reduced
92
Closed
7

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.2M
2
BP icon
BP
BP
+$4.27M
3
MRK icon
Merck
MRK
+$2.01M
4
UNP icon
Union Pacific
UNP
+$1.24M
5
ON icon
ON Semiconductor
ON
+$1.02M

Sector Composition

Rank Sector Weight
1 Technology 21%
2 Healthcare 18.86%
3 Financials 15.21%
4 Industrials 11.46%
5 Communication Services 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MCD icon
26
McDonald's
MCD
$195B
$15.5M 1.21%
64,369
-47
-0.1% -$11.2K
BRK.B icon
27
Berkshire Hathaway Class B
BRK.B
$1.13T
$15.5M 1.2%
56,772
-379
-0.7% -$106K
MRK icon
28
Merck
MRK
$318B
$15.2M 1.18%
202,639
-26,440
-12% -$2.01M
UNP icon
29
Union Pacific
UNP
$174B
$15.1M 1.18%
77,158
-5,745
-7% -$1.24M
J icon
30
Jacobs Solutions
J
$17B
$13.8M 1.07%
125,583
-544
-0.4% -$60.1K
ABBV icon
31
AbbVie
ABBV
$435B
$13.7M 1.06%
126,897
-475
-0.4% -$54.3K
CRM icon
32
Salesforce
CRM
$158B
$13.6M 1.06%
50,284
+203
+0.4% +$51.6K
UNH icon
33
UnitedHealth
UNH
$370B
$13.4M 1.04%
34,228
-573
-2% -$237K
ORCL icon
34
Oracle
ORCL
$423B
$12.5M 0.98%
143,992
-654
-0.5% -$57.8K
PG icon
35
Procter & Gamble
PG
$339B
$12.2M 0.95%
87,581
-283
-0.3% -$40.1K
EMR icon
36
Emerson Electric
EMR
$88.3B
$9.88M 0.77%
104,900
-800
-0.8% -$79.8K
ON icon
37
ON Semiconductor
ON
$31.6B
$9.82M 0.76%
214,596
-23,804
-10% -$1.02M
BXMT icon
38
Blackstone Mortgage Trust
BXMT
$2.38B
$9.76M 0.76%
321,801
+8,568
+3% +$272K
BMY icon
39
Bristol-Myers Squibb
BMY
$132B
$9.71M 0.75%
164,112
+812
+0.5% +$53.5K
PEP icon
40
PepsiCo
PEP
$190B
$9.34M 0.73%
62,082
-1,647
-3% -$255K
INTC icon
41
Intel
INTC
$513B
$9.29M 0.72%
174,252
-75
-0% -$4.07K
IBB icon
42
iShares Biotechnology ETF
IBB
$9.71B
$8.78M 0.68%
54,301
-125
-0.2% -$21K
VZ icon
43
Verizon
VZ
$196B
$8.46M 0.66%
156,582
+3,343
+2% +$185K
AXP icon
44
American Express
AXP
$230B
$8.26M 0.64%
49,277
CVS icon
45
CVS Health
CVS
$122B
$8.25M 0.64%
97,235
-249
-0.3% -$20.9K
RTX icon
46
RTX Corp
RTX
$301B
$7.45M 0.58%
86,697
-801
-0.9% -$68.5K
LIN icon
47
Linde
LIN
$226B
$7.04M 0.55%
24,007
-340
-1% -$103K
PFE icon
48
Pfizer
PFE
$153B
$6.83M 0.53%
158,885
-646
-0.4% -$28.6K
ADP icon
49
Automatic Data Processing
ADP
$108B
$6.56M 0.51%
32,807
-1,262
-4% -$260K
ABT icon
50
Abbott
ABT
$187B
$6.54M 0.51%
55,391
-400
-0.7% -$49.1K

Similar funds

Neville Rodie & Shaw's Q3 2021 Portfolio in Review

As of Q3 2021, Neville Rodie & Shaw held 270 positions worth $1.29B, down 0.89% from $1.3B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.8%. Neville Rodie & Shaw opened 6 new positions and exited 7, leaving the 270-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q3 2021 buy was Block Inc: 2,460 shares worth $590K.
  • Neville Rodie & Shaw added most to Accenture in Q3 2021, an estimated $390K increase.
  • Neville Rodie & Shaw's biggest Q3 2021 reduction was ExxonMobil, cutting an estimated $5.2M.
  • Neville Rodie & Shaw fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $519K.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.29B portfolio in Q3 2021.
  • Neville Rodie & Shaw opened 6 new positions and closed 7 in Q3 2021.
  • Neville Rodie & Shaw's portfolio value fell 0.89% quarter-over-quarter to $1.29B.

Based on Neville Rodie & Shaw's 13F filing for Q3 2021, filed 6 Oct 2021.